![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 14/605 | (2006.01) |
A61K 38/26 | (2006.01) |
(11) | Number of the document | 2490709 |
(13) | Kind of document | T |
(96) | European patent application number | 10825678.5 |
Date of filing the European patent application | 2010-10-21 | |
(97) | Date of publication of the European application | 2012-08-29 |
(45) | Date of publication and mention of the grant of the patent | 2014-11-26 |
(46) | Date of publication of the claims translation | 2015-02-25 |
(86) | Number | PCT/US2010/053570 |
Date | 2010-10-21 |
(87) | Number | WO 2011/050174 |
Date | 2011-04-28 |
(30) | Number | Date | Country code |
254490 P | 2009-10-23 | US | |
09173900 | 2009-10-23 | EP |
(72) |
ALAGARSAMY, Sudarkodi, US
JIANG, Guangcheng, US
RIVIERE, Pierre, NL
SCHTEINGART, Claudio, Daniel, US
SUEIRAS-DIAZ, Javier, US
WISNIEWSKI, Kazimierz, US
|
(73) |
Ferring BV,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Peptidiniai GLP-2 agonistai |
PEPTIDIC GLP-2 AGONISTS |
Payment date | Validity (years) | Amount | |
2024-10-07 | 15 | 289.00 EUR |
2025-10-21 |